home / lobbying / lobbying_activities

lobbying_activities: 1295387

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1295387 0ccfe849-a195-4e48-b731-78a120767ffd Q3 AMERICAN ASSOCIATION FOR GERIATRIC PSYCHIATRY 59251 AMERICAN ASSOCIATION FOR GERIATRIC PSYCHIATRY 2012 third_quarter MMM 1. Medicare Physician Fee Schedule - AAGP urges Congress to replace the current Medicare reimbursement formula with one that more accurately reflects the volume and intensity of services furnished to Medicare beneficiaries and to take action to avert future cuts in Medicare payments to physicians and other health care providers. AAGP also urges Congress to take action to avert all proposed reductions in Medicare physician reimbursements scheduled to take effect on January 1, 2013. 2. Support S. 374 and H.R. 2783, the "Medicare Mental Health Inpatient Equity Act," to amend Title XVIII (Medicare) of the Social Security Act to eliminate the 190-day lifetime limit on inpatient psychiatric hospital services. 3. Oppose proposals to shift Medicaid costs to states and families via block grants or overall caps on spending. 4. Oppose any Federal budget or funding agreement that would significantly cut, block grant, or impose harmful spending caps on the Medicaid program with special concern for persons with mental disorders, including senior citizens, who rely on Medicaid as a lifeline. 5. Oppose any cuts in Medicare or Medicaid programs that would adversely impact children and adults with behaviroral health disorders. 6. Support all efforts to ensure that any CMS demonstration programs for beneficiaries that are concurrently eligible for both Medicare and Medicaid ("dual eligibles"") provide protections for all dual eligibles with mental disorders, including access to existing provider networks, passive enrollment processes, retention of current Medicare protections and relevant quality measures. 7. Urge strong Congressional oversight of the implementation of demonstration programs under Section 2602 of the "Affordable Care Act" to ensure that these proposals contain critical protections for dually eligible (Medicare and Medicaid) individuals with mental illness. 8. Oppose the sections on review and reporting of antipsychotics, informed consent, and an IOM study and report (sections 4, 5, and 7) of S.3604, the "Improving Dementia Care Treatment for Older Adults Act of 2012". 9. Support a GAO study on the use of antipsychotic medications by nursing homes. HOUSE OF REPRESENTATIVES,SENATE   20000 0 0 2012-10-04T14:01:11.383000-04:00
Powered by Datasette · Queries took 11.64ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API